Avisi Technologies, Inc., an ophthalmic medical device company advancing novel, sight-saving technologies, presented positive twelve-month clinical data on VisiPlate® Aqueous Shunt from the VITA Trial ...
Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today reported financial results for the third quarter ended September 30, 2025 and ...
Hyperbaric oxygen therapy improves visual outcomes and preserves retinal structure in patients with central retinal artery occlusion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback